| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |